{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:03:31Z","timestamp":1793300611423,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.chom.2022.10.012","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T04:06:08Z","timestamp":1666325168000},"page":"1745-1758.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history"],"prefix":"10.1016","volume":"30","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Lusvarghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat J.","family":"Epsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Goguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Echegaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u2019Ana A.","family":"Coggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Mende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan C.","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek T.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda E.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet O.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Rozman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahaniyat","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Berjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Maves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milissa U.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal","family":"Mody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Huprikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Livezey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Hollis-Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Tribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Agan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Pollett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah C.","family":"Katzelnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9965-1289","authenticated-orcid":false,"given":"Carol D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2022.10.012_bib2","article-title":"Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020\u2013Dec 2021","author":"Bergeri","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.chom.2022.10.012_bib3","doi-asserted-by":"crossref","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa","volume":"376","author":"Pulliam","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.chom.2022.10.012_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.chom.2022.10.012_bib9","doi-asserted-by":"crossref","first-page":"eabn8543","DOI":"10.1126\/scitranslmed.abn8543","article-title":"SARS-CoV-2 BA.1 variant is neutralized by vaccine booster\u2013elicited serum but evades most convalescent serum and therapeutic antibodies","volume":"14","author":"Lusvarghi","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and Delta variants","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.chom.2022.10.012_bib11","doi-asserted-by":"crossref","first-page":"101542","DOI":"10.1016\/j.eclinm.2022.101542","article-title":"Immune response and reactogenicity\u00a0after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard\u00a0mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study","volume":"51","author":"Ascaso-Del-Rio","year":"2022","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.chom.2022.10.012_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.chom.2022.10.012_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJMc2202542","article-title":"Efficacy of a fourth dose of COVID-19 mRNA vaccine against omicron","volume":"386","author":"Regev-Yochay","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib15","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa2201570","article-title":"Protection by a fourth dose of BNT162b2 against omicron in Israel","volume":"386","author":"Bar-On","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJMoa2201688","article-title":"Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting","volume":"386","author":"Magen","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib17","doi-asserted-by":"crossref","first-page":"eabq2427","DOI":"10.1126\/sciimmunol.abq2427","article-title":"Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes","volume":"7","author":"Quandt","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.chom.2022.10.012_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.03.038","article-title":"mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron","volume":"185","author":"Gagne","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.chom.2022.10.012_bib22","article-title":"A bivalent omicron-containing booster vaccine against COVID-19","author":"Chalkias","year":"2022","journal-title":"Preprint at medRxiv."},{"key":"10.1016\/j.chom.2022.10.012_bib23","author":"Pfizer"},{"key":"10.1016\/j.chom.2022.10.012_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2206576","article-title":"Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5","volume":"387","author":"Hachmann","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib25","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1056\/NEJMc2206725","article-title":"Neutralization of the SARS-CoV-2 omicron BA.4\/5 and BA.2.12.1 Subvariants","volume":"386","author":"Qu","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib26","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1473-3099(22)00410-8","article-title":"Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection","volume":"22","author":"Yao","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chom.2022.10.012_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.chom.2022.10.012_bib28","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1256427","article-title":"Antibody landscapes after influenza virus infection or vaccination","volume":"346","author":"Fonville","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.chom.2022.10.012_bib29","article-title":"BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants","author":"R\u00f6ssler","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.chom.2022.10.012_bib30","article-title":"Mapping SARS-CoV-2 antigenic relationships and serological responses","author":"Wilks","year":"2022","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.chom.2022.10.012_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.07.018","article-title":"Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron","volume":"55","author":"van der Straten","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.chom.2022.10.012_bib32","article-title":"Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants","author":"Mykytyn","year":"2022","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.chom.2022.10.012_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001384","article-title":"Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus","volume":"19","author":"Amanat","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.chom.2022.10.012_bib34","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/v13122485","article-title":"SARS-CoV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity","volume":"13","author":"Neerukonda","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.chom.2022.10.012_bib35","article-title":"Understanding \u201chybrid immunity\u201d: comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines","author":"Epsi","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.chom.2022.10.012_bib36","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib37","doi-asserted-by":"crossref","first-page":"105162","DOI":"10.1016\/j.jcv.2022.105162","article-title":"Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization","volume":"150\u2013151","author":"Guo","year":"2022","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.chom.2022.10.012_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2022.10.012_bib39","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMc2114706","article-title":"Neutralization of the SARS-CoV-2 mu variant by convalescent and vaccine serum","volume":"385","author":"Uriu","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2022.10.012_bib40","article-title":"Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization","author":"Ho","year":"2021","journal-title":"Preprint at Res Sq"},{"key":"10.1016\/j.chom.2022.10.012_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.chom.2022.10.012_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","article-title":"Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies","volume":"593","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.chom.2022.10.012_bib43","series-title":"StatPearls","article-title":"Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19)","author":"Aleem","year":"2022"},{"key":"10.1016\/j.chom.2022.10.012_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.chom.2022.10.012_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.chom.2022.10.012_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2022.03.029","article-title":"SARS-CoV-2 Omicron triggers cross-reactive\u00a0neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals","volume":"30","author":"Richardson","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2022.10.012_bib47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1126\/science.1154137","article-title":"The global circulation of seasonal influenza A (H3N2) viruses","volume":"320","author":"Russell","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.chom.2022.10.012_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1126\/science.abk0058","article-title":"Antigenic evolution of dengue viruses over 20 years","volume":"374","author":"Katzelnick","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.chom.2022.10.012_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.chom.2022.10.012_bib50","article-title":"Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection","author":"Khoury","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.chom.2022.10.012_bib51","doi-asserted-by":"crossref","first-page":"15798","DOI":"10.1073\/pnas.1409171111","article-title":"Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013\u20132014 influenza season","volume":"111","author":"Linderman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2022.10.012_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248348","article-title":"Establishment of a well-characterized SARS-CoV-2 lentiviral Pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2","volume":"16","author":"Neerukonda","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.chom.2022.10.012_bib53","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12879-021-06233-1","article-title":"Prospective assessment of SARS-CoV-2 seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers","volume":"21","author":"Jackson-Thompson","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.chom.2022.10.012_bib54","article-title":"Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses","author":"Laing","year":"2021","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.chom.2022.10.012_bib55","doi-asserted-by":"crossref","first-page":"ofab556","DOI":"10.1093\/ofid\/ofab556","article-title":"COVID-19 outcomes among US Military Health System beneficiaries include complications across multiple organ systems and substantial functional impairment","volume":"8","author":"Richard","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.chom.2022.10.012_bib56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in\u00a0vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chom.2022.10.012_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In\u00a0vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.chom.2022.10.012_bib58","doi-asserted-by":"crossref","first-page":"bpaa014","DOI":"10.1093\/biomethods\/bpaa014","article-title":"Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200\u00a0bp tiled amplicons and Oxford nanopore rapid barcoding","volume":"5","author":"Freed","year":"2020","journal-title":"Biol. Methods Protoc."},{"key":"10.1016\/j.chom.2022.10.012_bib59","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J.\u00a0Open Source Software"},{"key":"10.1016\/j.chom.2022.10.012_bib60","article-title":"R: a language and environment for statistical computing","year":"2022","journal-title":"R Foundation for Statistical Computing"}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193131282200525X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193131282200525X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:31:51Z","timestamp":1761827511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193131282200525X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S193131282200525X"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2022.10.012","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.05.498883","asserted-by":"object"}]},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2022.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}